Role of Measurable Residual Disease in Older Adult Acute Myeloid Leukemia

被引：3

作者：

Li, Xueyao ^{[1
]}

Tong, Xiuzhen ^{[1
,2
]}

机构：

[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hematol, Guangzhou, Peoples R China

[2] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hematol, 58 Second Zhongshan Rd, Guangzhou 510080, Peoples R China

来源：

CLINICAL INTERVENTIONS IN AGING | 2023年 / 18卷

关键词：

detection method; risk-stratification marker; postremission decisions; personalized medicine; HEMATOPOIETIC-CELL TRANSPLANTATION; CLONAL HEMATOPOIESIS; PROGNOSTIC RELEVANCE; AML; MUTATIONS; AZACITIDINE; THERAPY; RISK; DECITABINE; MANAGEMENT;

D O I：

10.2147/CIA.S409308

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

There is overwhelming evidence indicating that the use of measurable residual disease (MRD) as a biomarker provides critical prognostic information and that MRD may have a role in directing postremission decisions. There are a variety of assays for MRD assessment, such as multiparameter flow cytometry and molecular assessment of MRD, which present different characteristics in patients older than 60 years of age. Due to multiple reasons related to age, the progress of older adult AML patients is rarely investigated, especially with respect to MRD. In this review, we will clarify the characteristics of different assays for assessing MRD, focusing on its role as a risk-stratification biomarker to predict prognostic information and its role in optimal postremission therapy among older adult AML patients. These characteristics also provide guidance regarding the potential to apply personalized medicine in older adult AML patients.

引用

页码：921 / 931

页数：11

共 66 条

[41] Prognostic Significance of the European LeukemiaNet Standardized System for Reporting Cytogenetic and Molecular Alterations in Adults With Acute Myeloid Leukemia [J].

Mrozek, Krzysztof ;

Marcucci, Guido ;

Nicolet, Deedra ;

Maharry, Kati S. ;

Becker, Heiko ;

Whitman, Susan P. ;

Metzeler, Klaus H. ;

Schwind, Sebastian ;

Wu, Yue-Zhong ;

Kohlschmidt, Jessica ;

Pettenati, Mark J. ;

Heerema, Nyla A. ;

Block, AnneMarie W. ;

Patil, Shivanand R. ;

Baer, Maria R. ;

Kolitz, Jonathan E. ;

Moore, Joseph O. ;

Carroll, Andrew J. ;

Stone, Richard M. ;

Larson, Richard A. ;

Bloomfield, Clara D. .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (36) :4515-4523

[42] Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML [J].

Nomdedeu, J. F. ;

Hoyos, M. ;

Carricondo, M. ;

Bussaglia, E. ;

Estivill, C. ;

Esteve, J. ;

Tormo, M. ;

Duarte, R. ;

Salamero, O. ;

de Llano, M. P. Q. ;

Garcia, A. ;

Bargay, J. ;

Heras, I. ;

Marti-Tutusaus, J. M. ;

Llorente, A. ;

Ribera, J. M. ;

Gallardo, D. ;

Aventin, A. ;

Brunet, S. ;

Sierra, J. .

LEUKEMIA, 2013, 27 (11) :2157-2164

[43] How to address second and therapy-related acute myelogenous leukaemia [J].

Oliai, Caspian ;

Schiller, Gary .

BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (01) :116-128

[44] MRD in AML: does it already guide therapy decision-making? [J].

Ossenkoppele, Gert ;

Schuurhuis, Gerrit Jan .

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, :356-365

[45] Prognostic Significance of NPM1 Mutations in the Absence of FLT3-Internal Tandem Duplication in Older Patients With Acute Myeloid Leukemia: A SWOG and UK National Cancer Research Institute/Medical Research Council Report (vol 33, pg 1157, 2015) [J].

Ostronoff, F. ;

Othus, M. ;

Lazenby, M. ;

Estey, E. ;

Appelbaum, F. R. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15) :1715-1715

[46] Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML) [J].

Patkar, Nikhil ;

Kakirde, Chinmayee ;

Shaikh, Anam Fatima ;

Salve, Rakhi ;

Bhanshe, Prasanna ;

Chatterjee, Gaurav ;

Rajpal, Sweta ;

Joshi, Swapnali ;

Chaudhary, Shruti ;

Kodgule, Rohan ;

Ghoghale, Sitaram ;

Deshpande, Nilesh ;

Shetty, Dhanalaxmi ;

Khizer, Syed Hasan ;

Jain, Hasmukh ;

Bagal, Bhausaheb ;

Menon, Hari ;

Khattry, Navin ;

Sengar, Manju ;

Tembhare, Prashant ;

Subramanian, Papagudi ;

Gujral, Sumeet .

LEUKEMIA, 2021, 35 (05) :1392-1404

[47] Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged 75 years or older [J].

Prassek, Victoria V. ;

Rothenberg-Thurley, Maja ;

Sauerland, Maria C. ;

Herold, Tobias ;

Janke, Hanna ;

Ksienzyk, Bianka ;

Konstandin, Nikola P. ;

Goerlich, Dennis ;

Krug, Utz ;

Faldum, Andreas ;

Berdel, Wolfgang E. ;

Woermann, Bernhard ;

Braess, Jan ;

Schneider, Stephanie ;

Subklewe, Marion ;

Bohlander, Stefan K. ;

Hiddemann, Wolfgang ;

Spiekermann, Karsten ;

Metzeler, Klaus H. .

HAEMATOLOGICA, 2018, 103 (11) :1853-1861

[48] Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy [J].

Pratcorona, Marta ;

Brunet, Salut ;

Nomdedeu, Josep ;

Maria Ribera, Josep ;

Tormo, Mar ;

Duarte, Rafael ;

Escoda, Lourdes ;

Guardia, Ramon ;

Queipo de Llano, M. Paz ;

Salamero, Olga ;

Bargay, Joan ;

Pedro, Carmen ;

Maria Marti, Josep ;

Torrebadell, Montserrat ;

Diaz-Beya, Marina ;

Camos, Mireia ;

Colomer, Dolors ;

Hoyos, Montserrat ;

Sierra, Jorge ;

Esteve, Jordi .

BLOOD, 2013, 121 (14) :2734-2738

[49] Acute Myeloid Leukemia With Translocation (8;21) or Inversion (16) in Elderly Patients Treated With Conventional Chemotherapy: A Collaborative Study of the French CBF-AML Intergroup [J].

Prebet, Thomas ;

Boissel, Nicolas ;

Reutenauer, Sarah ;

Thomas, Xavier ;

Delaunay, Jacques ;

Cahn, Jean-Yves ;

Pigneux, Arnaud ;

Quesnel, Bruno ;

Witz, Francis ;

Thepot, Sylvain ;

Ugo, Valerie ;

Terre, Christine ;

Recher, Christian ;

Tavernier, Emmanuelle ;

Hunault, Mathilde ;

Esterni, Benjamin ;

Castaigne, Sylvie ;

Guilhot, Francois ;

Dombret, Herve ;

Vey, Norbert .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) :4747-4753

[50] Evaluating measurable residual disease in acute myeloid leukemia [J].

Ravandi, Farhad ;

Walter, Roland B. ;

Freeman, Sylvie D. .

BLOOD ADVANCES, 2018, 2 (11) :1356-1366

← 1 2 3 4 5 6 7 →